5. Conclusion
The mortality rate was reported 4% and 32% in the intervention and
control groups, respectively. Moreover, the mean hospitalization days
were 7.02 vs. 10.83 in the PTX and control group, respectively.
Therefore, pentoxifylline increased the survival rate of hospitalized
COVID-19 patients and played a preventive role for COVID-related
mortality and morbidity such as ARDS.